Overview
Arctoris is a leading technology-enabled drug discovery company that bridges the gap between digital AI models and physical biological experimentation. Its core platform, Ulysses, is an advanced robotic laboratory ecosystem designed to generate high-quality, reproducible, and machine-learnable data at scale. By 2026, Arctoris has solidified its position as the 'physical layer' for AI-first biotech firms, providing the ground-truth data necessary to train and validate generative chemistry and protein folding models. The platform automates complex biochemical, cell-based, and molecular biology assays, capturing thousands of data points with full metadata and environmental telemetry. This closed-loop approach allows researchers to transition from hypothesis to validated data in a fraction of the time required by traditional Contract Research Organizations (CROs). The Arctoris architecture is designed for deep integration, allowing AI agents to autonomously design experiments, trigger robotic execution, and ingest results for real-time model refinement. This makes it an essential infrastructure for the next generation of precision medicine and rapid therapeutic development.